Clinical Trial Update: Detection of Diffuse Scar in Patients With Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial examining detection of diffuse scar in patients with Type 2 diabetes mellitus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Diabetes Mellitus, Type II | Phase 4 | Status: WITHDRAWN